Novartis data at ASCO and EHA reinforce company’s commitment to reimagining cancer

Novartis will present data from across its oncology portfolio at the upcoming 54th Annual Meeting of the American Society of Clinical Oncology (ASCO) to be held June 1-5 in Chicago; and the 23rd Annua…
Read the full story: Breaking World Pharma News